Your browser doesn't support javascript.
loading
Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival.
Chen, Kai-Lin; Chen, Jie; Rao, Hui-Lan; Guo, Ying; Huang, Hui-Qiang; Zhang, Liang; Shao, Jian-Yong; Lin, Tong-Yu; Jiang, Wen-Qi; Zou, De-Hui; Hu, Li-Yang; Wirian, Michael Lucas; Cai, Qing-Qing.
Afiliación
  • Chen KL; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, 510060, Guangdong, P. R. China. chenkl@sysucc.org.cn.
  • Chen J; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, P. R. China. chenkl@sysucc.org.cn.
  • Rao HL; Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology, Radiotherapy Department, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, 510120, Guangdong, P. R. China. huanghui765@hotmail.com.
  • Guo Y; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, 510060, Guangdong, P. R. China. raohl@sysucc.org.cn.
  • Huang HQ; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, P. R. China. raohl@sysucc.org.cn.
  • Zhang L; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, 510060, Guangdong, P. R. China. guoying@sysucc.org.cn.
  • Shao JY; Clinical Trial Center, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, P. R. China. guoying@sysucc.org.cn.
  • Lin TY; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, 510060, Guangdong, P. R. China. huanghq@sysucc.org.cn.
  • Jiang WQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, P. R. China. huanghq@sysucc.org.cn.
  • Zou DH; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA. liazhang@mdanderson.org.
  • Hu LY; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, 510060, Guangdong, P. R. China. shaojy@sysucc.org.cn.
  • Wirian ML; Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, P. R. China. shaojy@sysucc.org.cn.
  • Cai QQ; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, 510060, Guangdong, P. R. China. linty@sysucc.org.cn.
Chin J Cancer ; 34(5): 225-34, 2015 May 28.
Article en En | MEDLINE | ID: mdl-26058465
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pronóstico / Activación Viral / Linfoma de Células B Grandes Difuso / Rituximab / Hepatitis B Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Chin J Cancer Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pronóstico / Activación Viral / Linfoma de Células B Grandes Difuso / Rituximab / Hepatitis B Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Chin J Cancer Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article